Glycopeptide-induced neutropenia: Cross-reactivity between vancomycin and teicoplanin

Annals of Pharmacotherapy

Volumn 41, Issue 5, 2007, Pages 891-894

  Hsiao, Shu Hwa ^a   Chang, Chia Ming ^a   Tsai, Jui Chen ^a   Lin, Chia Yin ^a   Liao, Li Hsiang ^a   Lin, Wen Liang ^a   Wu, Ta Jen ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cross reactivity; Glycopeptide; Neutropenia; Teicoplanin; Vancomycin

Indexed keywords

FUSIDIC ACID; GLYCOPEPTIDE; MECOBALAMIN; NICAMETATE; PARACETAMOL; TEICOPLANIN; THIAMINE; TRAMADOL; VANCOMYCIN; ZOLPIDEM;

ADULT; AGRANULOCYTOSIS; ARTICLE; BACTEREMIA; CASE REPORT; CROSS REACTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; NEUTROPENIA; NEUTROPHIL COUNT; OSTEOMYELITIS; PRIORITY JOURNAL; THERAPY EFFECT;

ANTI-BACTERIAL AGENTS; CROSS REACTIONS; FEMALE; HUMANS; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPENIA; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 34248587207     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H633     Document Type: Article

References (21)

1. de Lalla F, Tramarin A. A risk-benefit assessment of teicoplanin in the treatment of infections. Drug Saf 1995;13:317-28.
2. Van Bambeke F, Van Laethem Y, Courvalin P, Tulkens PM. Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs 2004;64:913-36. DOI 10.2165/00003495-200464090-00001
3. Del Favero A, Patoia L, Bucaneve G, Biscarini L, Menichetti F. Leukopenia with neutropenia associated with teicoplanin therapy. DICP 1989; 23:45-7.
4. Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138-41.
5. Morris A, Ward C. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. J Infect 1991;22:217-23. DOI 10.1016/S0163-4453(05)80002-7
6. Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother 2006;40:224-8. Epub 24 Jan 2006. DOI 10.1345/aph.1G436
7. LeFrock J, Ristuccia A. Teicoplanin in the treatment of bone and joint infections: an open study. J Infect Chemother 1999;5:32-9. DOI 10.1007/s101560050005
8. Pauluzzi S, Del Favero A, Menichetti F, et al. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study. J Antimicrob Chemother 1987;20:431-8.
9. Calain P, Krause KH, Vaudaux P, et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis 1987;155:187-91.
10. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
11. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-24.
12. Segarra-Newnham M, Tagoff SS. Probable vancomycin-induced neutropenia. Ann Pharmacother 2004;38:1855-9. Epub 5 Oct 2004. DOI 10.1345/aph.1E187
13. Schwartz MD. Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody. Pharmacotherapy 2002;22:783-8. DOI 10.1592/phco.22.9. 783.34059
14. Sanche SE, Dust WN, Shevchuk YM. Vancomycin-induced neutropenia resolves after substitution with teicoplanin. Clin Infect Dis 2000;31:824-5. DOI 10.1086/314028
15. Kirkwood CF, Smith LL, Rustagi PK, Schentag JJ. Neutropenia associated with beta-lactam antibiotics. Clin Pharm 1983;2:569-78.
16. McElrath MJ, Goldberg D, Neu HC. Allergic cross-reactivity of teicoplanin and vancomycin (letter). Lancet 1986;1:47.
17. Knudsen JD, Pedersen M. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin. Scand J Infect Dis 1992;24: 395-6.
18. Davenport A. Allergic cross-reactivity to teicoplanin and vancomycin (letter). Nephron 1993;63:482.
19. Marshall C, Street A, Galbraith K. Glycopeptide-induced vasculitis - cross-reactivity between vancomycin and teicoplanin. J Infect 1998;37: 82-3. DOI 10.1016/S0163-4453(98)91077-5
20. Khurana C, de Belder MA. Red-man syndrome after vancomycin: potential cross-reactivity with teicoplanin. Postgrad Med J 1999;75:41-3.
21. Padial MA, Barranco P, Lopez-Serrano C. Erythema multiforme to vancomycin (letter). Allergy 2000;55:1201. DOI 10.1034/j.1398-9995.2000.00549.x